{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:36:55Z","timestamp":1768714615760,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ygyno.2023.03.007","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T15:59:50Z","timestamp":1679068790000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management"],"prefix":"10.1016","volume":"172","author":[{"given":"B.","family":"Hapuarachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Tidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Romanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ireson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9223","key":"10.1016\/j.ygyno.2023.03.007_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(00)02432-6","article-title":"Choriocarcinoma and partial hydatidiform moles","volume":"356","author":"Seckl","year":"2000","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.007_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"FIGO staging for gestational trophoblastic neoplasia 2000","volume":"77","author":"Figo Oncology Committee","year":"2002","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2023.03.007_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int J Gynecol Obstet [Internet]"},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.007_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygyno.2015.01.530","article-title":"Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome","volume":"137","author":"Savage","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.03.007_bb0025","first-page":"465","article-title":"Management of brain metastases in patients with high-risk gestational trophoblastic tumors","volume":"47","author":"Newlands","year":"2002","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.007_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10147-018-1337-9","article-title":"Gestational trophoblastic neoplasia with brain metastasis at initial presentation: a retrospective study","volume":"24","author":"Gavanier","year":"2019","journal-title":"Int J Clin Oncol"},{"issue":"suppl_4","key":"10.1016\/j.ygyno.2023.03.007_bb0035","doi-asserted-by":"crossref","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","article-title":"EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours","volume":"28","author":"Le Rhun","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.007_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.30911","article-title":"Leptomeningeal metastasis from systemic cancer: review and update on management","volume":"124","author":"Wang","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2023.03.007_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gore.2019.06.002","article-title":"Leptomeningeal spread of gestational trophoblastic neoplasia in a 19-year old woman","volume":"29","author":"Gwacham","year":"2019","journal-title":"Gynecol Oncol Rep"},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.007_bb0050","first-page":"94","article-title":"CSF\/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor","volume":"45","author":"Bakri","year":"2000","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.007_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.2012.43.1817","article-title":"EMA\/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis","volume":"31","author":"Alifrangis","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2023.03.007_bb0060","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","article-title":"EMA\/CO for high-risk gestational trophoblastic tumors results from a cohort of 272 patients","volume":"15","author":"Bower","year":"1997","journal-title":"J Clin Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.007_bb0065","first-page":"1547","article-title":"Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease","volume":"82","author":"Dobson","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.007_bb0070","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/ijc.33403","article-title":"M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin \/ cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia","volume":"148","author":"Singh","year":"2021","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.007_bb0075","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1200\/JCO.2000.18.4.854","volume":"18","author":"Newlands","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.007_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002800000118","article-title":"Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis","volume":"46","author":"Tetef","year":"2000","journal-title":"Cancer Chemother Pharmacol [Internet]"},{"issue":"5","key":"10.1016\/j.ygyno.2023.03.007_bb0085","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3171\/jns.1997.87.5.0694","article-title":"Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases","volume":"87","author":"Chamberlain","year":"1997","journal-title":"J Neurosurg"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:02:57Z","timestamp":1758772977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823001324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":17,"alternative-id":["S0090825823001324"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}